摘要
目的:分析p53基因突变型脑胶质瘤患者抗肿瘤治疗的药学监护过程,为该类患者的临床合理治疗提供参考。方法:临床药师利用自身专业特点,协助临床医生针对该例p53基因突变型脑胶质瘤患者制定了个体化的放化疗方案,并开展了药学监护和用药宣教。结果与结论:在临床医生和临床药师的共同努力下,患者病情得到有效控制,肿瘤未再明显进展,同时患者对治疗的信心增强,用药依从性也显著提高。
Objective:To analyze the pharmaceutical care process of antitumor therapy for patients with p53 gene mutation glioma to provide reference for reasonable clinical treatment of such patients.Methods:With professional expertise,clinical pharmacists assisted clinicians in formulating individualized chemoradiotherapy regimens for patients with p53 gene mutation glioma,and carried out pharmaceutical care and drug use propaganda and education.Results and Conclusion:With joint efforts of clinicians and clinical pharmacists,the patient's condition was effectively controlled and the tumor did not progress significantly,with enhanced confidence in treatment and significantly improved drug compliance.
作者
王安琪
沈李奎
赵一凡
朱莹
WANG An-qi;SHEN Li-kui;ZHAO Yi-fan;ZHU Ying(Suzhou Kowloon Hospital of Shanghai Jiao Tong University School of Medicine,Suzhou Jiangsu 215028,China)
出处
《抗感染药学》
2022年第3期433-436,共4页
Anti-infection Pharmacy
基金
苏州科技发展计划项目(编号:SYSD2019175)
苏州“科教兴卫”青年项目(编号:KJXW2019076)。
作者简介
王安琪(1992—),男,主治医师;通信作者:朱莹(1991—),女,临床药师【电子邮箱】1305502740@qq.com。
